Glypican-3-CAR T cells have previously been developed as second-generation constructs [14,56], subsequently corroborated by the co-secretion of soluble cytokines like IL-15 and/or IL-21 for the improvement of anti-tumor function [57]. The gene discussed is IL21; the disease is neoplasm.